Home World News Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ World News Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 959 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Air Force Academy Cadet Donates 19-Inch Afro and Fundraises $39,000 for... July 7, 2021 Promising pCR Rates with Neoadjuvant Durvalumab Plus Platinum-based Chemotherapy Combined with... July 29, 2025 FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory... March 18, 2021 Virtual Mind–Body Fitness Classes Show Unexpected Benefit in People with Cancer December 15, 2023 Load more HOT NEWS New Low-Powered Implantable Device Monitors Soft Tissue for Signs of Breast... FDA Approves Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer Treatment for Oropharyngeal Cancer: Investigating Ways to Do Less Harm FDA Proposes Changes to Mammography Standards to Inform Women About Breast...
